GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genexine Inc (XKRX:095700) » Definitions » Pre-Tax Income

Genexine (XKRX:095700) Pre-Tax Income : ₩-54,508 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Genexine Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Genexine's pretax income for the three months ended in Mar. 2024 was ₩-11,566 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-54,508 Mil. Genexine's pretax margin was -557.86%.

During the past 13 years, Genexine's highest Pretax Margin was 148.49%. The lowest was -1510.41%. And the median was -138.96%.


Genexine Pre-Tax Income Historical Data

The historical data trend for Genexine's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genexine Pre-Tax Income Chart

Genexine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16,509.20 27,535.90 -48,561.06 -56,831.17 -66,860.30

Genexine Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23,917.93 -24,564.69 -20,939.66 2,561.99 -11,565.60

Competitive Comparison of Genexine's Pre-Tax Income

For the Biotechnology subindustry, Genexine's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genexine's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genexine's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Genexine's Pre-Tax Income falls into.



Genexine Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Genexine's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-41240.886+0+-4110.901+1263.871+-22772.381
=-66,860

Genexine's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-12644.403+0+-639.11+309.587+1408.327
=-11,566

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-54,508 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genexine  (XKRX:095700) Pre-Tax Income Explanation

Genexine's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-11565.599/2073.219
=-557.86%

During the past 13 years, Genexine's highest Pretax Margin was 148.49%. The lowest was -1510.41%. And the median was -138.96%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genexine Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Genexine's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Genexine (XKRX:095700) Business Description

Traded in Other Exchanges
N/A
Address
700 Daewangpangyo-ro, Gyeonggi-do, Korea Bio Park Building B, Bundang-gu, Seongnam-si, KOR, 13488
Genexine Inc is a clinical-stage biotechnology company. It is focused on the development and commercialization of immunotherapeutics and next-generation long-acting biologics. Its primary technologies are Therapeutic DNA vaccine technology and Hyfc platform. The company's product pipeline includes products such as GX-H9, GX-E2, GX-G3, GX-G6, and Papitrol-188 among others.

Genexine (XKRX:095700) Headlines

No Headlines